Skip to content

NewsBlazeAU – Lifestyle

Author: Latigo Biotherapeutics, Inc

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering

August 6, 2026

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.